A PHP Error was encountered

Severity: Warning

Message: file_get_contents(https://...@pubfacts.com&api_key=b8daa3ad693db53b1410957c26c9a51b4908&a=1): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests

Filename: helpers/my_audit_helper.php

Line Number: 176

Backtrace:

File: /var/www/html/application/helpers/my_audit_helper.php
Line: 176
Function: file_get_contents

File: /var/www/html/application/helpers/my_audit_helper.php
Line: 250
Function: simplexml_load_file_from_url

File: /var/www/html/application/helpers/my_audit_helper.php
Line: 1034
Function: getPubMedXML

File: /var/www/html/application/helpers/my_audit_helper.php
Line: 3152
Function: GetPubMedArticleOutput_2016

File: /var/www/html/application/controllers/Detail.php
Line: 575
Function: pubMedSearch_Global

File: /var/www/html/application/controllers/Detail.php
Line: 489
Function: pubMedGetRelatedKeyword

File: /var/www/html/index.php
Line: 316
Function: require_once

A case of insulinoma with hypoglycemia that was better managed with lanreotide than octreotide. | LitMetric
Browse Categories

A case of insulinoma with hypoglycemia that was better managed with lanreotide than octreotide.

Keiko Yamaoka Shuichi Nagashima Nobukazu Okada Nagisa Sawayama Shinsuke Saito Manabu Takahashi Kenta Okada Kazuhiro Endo Masaru Koizumi Hideki Sasanuma Ken Ebihara Atsuko Kasajima Noriyoshi Fukushima Naohiro Sata Shun Ishibashi

Clin Case Rep

Division of Endocrinology and Metabolism Department of Medicine Jichi Medical University Shimotsuke Japan.

Published: May 2021

AI Article Synopsis

  • Long-acting somatostatin analogs like lanreotide slow release (LAN-SR) and octreotide long-acting release (OCT-LAR) help reduce hypoglycemia in patients with insulinoma.
  • * Some patients with insulinoma may experience greater benefits from LAN-SR compared to OCT-LAR.
  • * These treatments provide a more effective management option for glucose control in individuals with this condition.

Article Abstract

Long-acting somatostatin analogs, including lanreotide slow release (LAN-SR) and octreotide long-acting release (OCT-LAR), can improve hypoglycemia in insulinoma. LAN-SR may be more beneficial in some patients with insulinoma than OCT-LAR.

Download full-text PDF

 Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8133073PMC
http://dx.doi.org/10.1002/ccr3.4118DOI Listing

Publication Analysis

Top Keywords

octreotide long-acting
8
case insulinoma
4
insulinoma hypoglycemia
4
hypoglycemia better
4
better managed
4
managed lanreotide
4
lanreotide octreotide
4
long-acting somatostatin
4
somatostatin analogs
4
analogs including
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!

Privacy Policy Site Map

© LitMetric 2025. All rights reserved.